Allergy Therapeutics Share Discussion Threads

[totally banjo] 16/10/2024 15:53

Very positive day! The shares I bought in my ISA a couple of weeks ago are now showing a profit, which is nice!

What AGY I had left in my normal share dealing account from years ago is another matter!

[totally banjo] 16/10/2024 12:01

The extension to the loan facility from January 2027 to October 2030 is very important for various reasons:

Firstly as the CEO Manuel Llobet implies, it takes the pressure off AGY in moving forward knowing they have the funds to draw on.

Grass MATA MPL starts the German approval stage (plan was Q4 2024) with results due roughly in mid/late 2025 and if granted will see this product being sold within the largest allergen immunotherapy market in Europe! This would then forward to a USA approval route which if successful gives access (est. 2027) to a $2bn market!

VLP Peanut Programme, AGY are expecting the preliminary results of this trial during Q4 this year leading to FDA approvals, going to market....2028-2030? Revenues would be massive!

Still lots of hurdles to overcome and we will get an update on the current product sales along with updates on the various trials and approvals with the preliminary results estimated to be published end of this month.

Very exciting times, in my opinion

[jimmyloser] 16/10/2024 10:54

Who are Hayfin?

[totally banjo] 16/10/2024 10:01

Looks like our broker has updated on today's news, I'll have a look later

[totally banjo] 16/10/2024 09:20

Morning all, this is excellent news! Busy at moment, back later

[jimmyloser] 16/10/2024 08:46

EDITED upwards

impo (lol) we have an upbeat Manuel on our hands and the next COUPLE of announcements should increase interest.

I hate predicted prices but for a bit o' fun only, I will increase my earlier prediction to 7p/9p by Christmas.
Hohoho

[joeblogg2] 16/10/2024 08:36

Any thoughts jimmy on .1, looks like funding sorted bringing interest

[joeblogg2] 16/10/2024 06:40

Is it a typo?

[joeblogg2] 16/10/2024 06:39

Yes that is the bit I don’t like :(

[joeblogg2] 16/10/2024 06:16

Morning jimmy, banjo and a few other holders!! The Group continues to deliver against its plan of improvements to its operational and quality systems, this has paved the way for increased manufacturing capacity and a return to sales growth which will be further detailed in the preliminary results.

[jimmyloser] 16/10/2024 06:05

Remember...There will be no shortage of funds!!!!Funding is a sideshow!!!!Light the blue touch paper!!!!A red letter day for sure!! Enjoy.

[joeblogg2] 15/10/2024 10:23

Thanks jimmy and banjo!! It is not followed much but hopefully about to change as company progresses

[totally banjo] 15/10/2024 10:15

Cheers for your view jimmy

[jimmyloser] 15/10/2024 09:51

My view and this is (100% IMPO)is that to-day this is a high class well run British business on the cusp of making significant returns for shareholders and bringing much needed relief to tens of thousands of allergy sufferers.
It has been a long and at times painful and arduous journey for those involved, especially those at the cutting edge but their skill and persistence is about to start to redeem historic lost credibility.
They have a very strong and experienced B.O.D. supported by very clever R&D people and they have the eyes and ears of the medical world on them at this time.
With Simon Chen and David Ball having played fair with us so far and having so much skin and belief in this venture, I see issues such as funding as being a mere sideshow and especially in the hands of Nash and Fricker at CAVS.
I recently posted some of Senor Llobets recents quotes from the last few RNS's. I do urge people to read them again. Right now, people are wary and it is for AGY to change that by delivering. To paraphrase the words of St Francis
"Where there is doubt, let them bring faith.
Where there is despair, let them bring hope".

impo/dyor - Not for widows and orphans at this time!

[totally banjo] 14/10/2024 23:27

"joeblogg214 Oct '24 - 09:53 - 5059 of 5062

Guys before I buy more what type of funding ?"

We got thrashed at darts again (9-0)!

If Jimmy is about he might be able to put forward his view?

My own personal view is that this is a high risk stock at the moment and likely to be this way for six months at least!

The 'potential' for huge gains from the current share price is there but in my opinion there is a lot that could go wrong, especially with the PROTECT trial results and then getting FDA approvals will take a few years!


Grass MATA MPL is also a major product line which I believe is closer in gaining both USA and European approvals compared to the VLP Peanut vaccine!

All 'potential' at the moment is the key word,imo

[totally banjo] 14/10/2024 14:17

Preliminary results are due in the next few weeks which will be interesting to see if sales of existing products have increased during that time frame and after.

There's obviously a lot going on in the background regarding trials and licenses so we might get an update on progress.

[joeblogg2] 14/10/2024 13:29

Thanks banjo just hope it is not a discounted issue

[totally banjo] 14/10/2024 10:54

Hi Joe, all I know is what has been via RNS with an update 1st October 2024:

Update on funding and preliminary results


01 October 2024 Allergy Therapeutics plc (AIM: AGY), the integrated commercial biotechnology company specialising in allergy vaccines, today announces an update on the Group's working capital position.

Following tight cost control initiatives and changes to the phasing of R&D expenditure, the Group has successfully extended its cash runway into late-October.

There remains a further £12.5m of uncommitted funding available under the Amended Loan Facility and the Company is at an advanced stage on further debt funding to support its ongoing operations and development pipeline.

Preparation of Allergy Therapeutics' preliminary financial results for the year ended 30 June 2024 is well underway and the Group now expects to publish its report by the end of October.

[joeblogg2] 14/10/2024 08:53

Guys before I buy more what type of funding ?

[totally banjo] 09/10/2024 13:18

Hi Joe, I'm not sure how much the peanut (PROTECT) trial costs but it won't be cheap! Therefore you would think AGY must believe they have a 90%+ chance of a successful outcome?

[joeblogg2] 09/10/2024 11:54

guys have been following agy for years and have bought a few on spread with IG as my cash situation pretty bad these days due to losses over the years. Funding is needed for ongoing trials , the peanut one they must have some idea if it works or not by now as safety seems ok??